argument about a 'proving dose' does not really apply. The fact that some (by no means all) provings used a 30C dose certainly does not mean that 30C is not used therapeutically. We determined the two doses through consultations with homeopaths, and I am a trained homeopath myself. I therefore see neither the 'oversight' nor the 'methodological flaw' which Lewith points out. To imply that we neglected the principles of homeopathic practice can only be based on a lack of understanding of our study: in everyday homeopathic practice arnica is used in acute prescribing for tissue trauma, and this was the basis of our hypothesis.
Dr Matthews argues that NNT could have been used for a sample size calculation to determine a 'worthwhile' effect. In hindsight this makes sense to me, even though we would not have had the funds for a trial with 200 patients. Matthews also mentions that our trial could be valuable for a systematic review. I agree, and would add that the effect would be to make the findings from the two existing reviews 2,3 even less encouraging than they already are.
Dr Fisher and his colleagues, in voicing suspicion that our trial was underpowered, cite a further trial (sample size=37) in support of their belief that, homeopathic arnica is, after all, effective. 4 The cited study, however, was a trial not of homeopathic arnica alone but of arnica in combination with a herbal cream applied topically. The conclusion of our paper was, 'The results of this trial do not suggest that homeopathic arnica has an advantage over placebo in reducing postoperative pain, bruising and swelling in patients undergoing elective hand surgery'. I fail to see how we confused 'absence of proof' with 'proof of absence'. how things come to be and provided a mechanism for reasoning that could be applied to any academic discipline. In modern times, when medicine is threatened by information-overload, the philosophical process (inquiry, critical reasoning, analysis) can offer valuable insights for practice. However, as Dr Harper indicates, acceptance demands an end to the misconception that philosophy is incompatible with practical science. The general view is that, while science has answers that command widespread agreement, philosophy is interested in matters on which there is less consensus. By challenging concepts and assumptions, the philosophical approach can generate new perspectives in science. Advances in genomic biotechnology, for instance, illustrate the difficulty of deciding what to do with scientific discoveries. We need to consider what society we wish to have and our relationships with each other and our surroundings, which depend on our conception of ourselves as human beings at societal level. This is where, in our opinion, Dr Harper's article is overambitious in scope. In trying to cover a large area, he omits certain issues that are important in explicating/ exploring the common ground between philosophy and medicine; for example, how should ethics be applied in the medical arena, or how does morality ethically connect with human society? His choice of philosophers was necessarily limited, but in an article about science as applied to medicine we would have included the following: Thales of Miletus, the first natural scientist and analytical philosopher in Western intellectual history; Aristotle, for his observation, methodological classification and empirical analysis; Bertrand Russell, for his logical analysis; 2 and Michel Foucault, for his insightful analysis of scientific knowledge and social control. 3 onset. Their results are nonetheless based on soft data. A considerable proportion of 'influenza-like illnesses' in patients of all ages are not due to influenza viruses (as Da Silva et al. acknowledge) and this proportion is liable to increase both when 'flu' is reported in the media as being present and when patients and doctors become aware that a cure may be available.
Hence, it will be very difficult to assess whether such drugs are genuinely useful in general practice unless one or more studies are done in which a diagnostic virus laboratory is used to confirm the cause in each case. Given the considerable practical difficulties of doing this, a wellprepared prospective study is necessary. In its absence, there is a danger of overprescribing; and, just as bad, overuse will discredit a useful group of drugs. It would be in the interest of the manufacturer(s) to sponsor such a study, as well as a search for a reliable and fast (51 hour Another important issue is the manner in which the authors of clinical note entries identify themselves. The lack of a legible name, position and pager number identifying note entries has major implications in large and complex hospital systems where the case notes are an important means of communication between teams from different specialties. At the John Radcliffe Hospital between February and August 2002 we audited how well authors of note entries for patients on the colorectal surgical firm identified themselves, by looking for a legible name, rank and pager number. A total of 540 note entries in 20 patients made in 2002 were compared with 480 note entries made between 1995 and 1999 for the same group of patients. In the earlier series a legible name, rank and pager number were included in respectively 31%, 29% and 49% of note entries, and this increased to 56%, 49% and 72% in 2002. Although the new figures represent an improvement, they point to persistent deficiencies in the way authors of note entries identify themselves. We therefore support the conclusion of Rodríguez-Vera et al. that clinical notes should become computer based.
